OTC drug makers, private research institutes, device manufacturers and others across the life science spectrum benefit from Boyden’s specialised expertise in meeting distinct talent needs.
We discover the right leaders in emerging global talent pools to turn specialist investment and scientific breakthroughs into medical and commercial advantage.
We help our clients to acquire leaders to address the challenges and opportunities of our time – turning discoveries into treatments and better patient outcomes.
The convergence of technology and healthcare drives major growth worldwide, promoting healthier and better lives.
We help clients to leverage the astonishing capabilities emerging in the diagnosis, treatment and management of disease.
Organisations are shifting from volume- to value-based models, creating new patient segments and targeting pharmerging markets. We connect our clients to leaders on the frontiers of change.
Driving value and growth means aligning the board to the business. In an era of on-going activism, boards are under more pressure to deliver corporate results, maintain strong compliance and protect all stakeholders.
Exceptional HR leadership is a key strategic enabler, re-defining an organisation and transforming the HR function.
A strong private equity market is fueling intense competition for talent to lead portfolio companies. We focus on securing our clients’ investments by putting leaders at the helm who can decisively confront challenges, put strategy into action, and balance caution with innovation to optimize performance.
Boyden has a deep understanding of the professional services sector, because we are a part of it. Our organisational structure mirrors that of our clients, and our insider’s perspective enhances every search.